Effect of exercise trainings in patients with heart failure

The comparison of the effect of endurance and combined endurance-resistance trainings on some cardiovascular markers in patients with heart failure undergoing coronary artery angioplasty

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015092916532N3

Enrollment

Registered

2015-10-09

Start date

2015-10-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure. Cardiac, heart or myocardial failure NOS

Interventions

Intervention 1: In endurance training group, patients participate in the exercise program, three days a week for seven weeks. Each session started with a 5 minute warm up and ends with 5 minutes cool

Rehabilitation

Patients in control group will not participate in a specific exercise program and received only conventional therapy, including drug therapy, advice on nutrition and recommendations on physical activi

In endurance training group, patients participate in the exercise program, three days a week for seven weeks. Each session started with a 5 minute warm up and ends with 5 minutes cool down. Training s

In combined endurance-resistance training group, Patients participate in the exercise program, three days a week for seven weeks. Each session started with a 5 minute warm up and ends with 5 minutes c

Eligibility

Sex/Gender

All

Age

40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with heart failure and ejection fraction=40% undergoing coronary artery angioplasty; NYHA functional class I-III; Stable pharmacological treatment Exclusion criteria: NYHA functional class IV; Uncontrolled arrhythmia; Uncontrolled angina pectoris; Severe type of kidney and lung disease; Musculoskeletal and cerebrovascular disease preventing exercise testing or training; Any changes in drug therapy; presence of signs or symptoms of ischemia

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
NT-proBNP. Timepoint: at entry and after 7 weeks. Method of measurement: using blood sampling.;High-sensitivity CRP. Timepoint: at entry and after 7 weeks. Method of measurement: using blood sampling.;Heart rate variability. Timepoint: at entry and after 7 weeks. Method of measurement: using rhythm holter monitoring.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara Abolahrari Shirazi

Shiraz University of Medical Sciences, Rehabilitation Sciences Faculty

sa_ahrari@yahoo.com+98 71 3627 1551

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026